Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04419870 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 72 years later May 1, 2027 → May 1, 2099
See other at-risk trials from National Human Genome Research Institute (NHGRI)

Record History

The 50 most recent of 370 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from May 1, 2027 to May 1, 2099v370
  2. Minor Re-verified, no change to tracked fieldsv369
  3. Minor Eligibility criteria shortened, about 1 wordv368 See this version in full on ClinicalTrials.gov ↗
  4. Minor 2 versions Re-verified since Jun 12, 2026, no change to tracked fieldsv366-v367
  5. Notable Primary and study completion pushed from May 1, 2026 to May 1, 2027v365
Show 44 earlier versionsHide 44 earlier versions
  1. Minor 3 versions Re-verified since Jun 13, 2025, no change to tracked fieldsv362-v364
  2. Notable Primary and study completion dates: May 1, 2025 to May 1, 2026v361
  3. Minor Study Identification, Study Status, Study Description, Arms and Interventions, Eligibilityv360
  4. Minor 7 versions Re-verified since Apr 27, 2024, no change to tracked fieldsv353-v359
  5. Minor Eligibility criteria expanded, about 29 wordsv352 See this version in full on ClinicalTrials.gov ↗
  6. Notable Enrollment target: 200 to 400v351
  7. Minor Study Identification, Study Status, Eligibilityv350
  8. Minor 8 versions Re-verified since Jun 27, 2022, no change to tracked fieldsv342-v349
  9. Minor Study Status, Oversight, Outcome Measures, Eligibilityv341
  10. Minor 20 versions Re-verified since May 24, 2022, no change to tracked fieldsv321-v340
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: Mitochondrial disease is a rare disorder. It can cause poor growth, developmental delays, muscle weakness, and other symptoms. The disease is usually inherited. It can be present at birth or develop later in life. Infection is a major cause of disease and death in people with this disease. Researchers want to learn more about these infections and the declining health of people who have this disease. To do this, researchers will study the DNA of people who become ill. Their DNA will be compared to the DNA of their household/family members. Objective: To learn more about how genes affect people with mitochondrial disease. Eligibility: People age 2 months and older with mitochondrial disease and their household/family members. .\<TAB\> Design: Participants will complete a questionnaire about their health history. Their medical records may be reviewed. They will give a blood sample. If the participant becomes ill, they may have a videoconference with a doctor or nurse at the NIH to perform a physical exam. They may be contacted after their illness to give updates on their health. They may be asked to give extra blood samples or complete extra questionnaires. Participants' genetic data will be put into a database. The data will be labeled with a code and not their name. The data will be shared with other researchers. Participation lasts about 1 year. This may be extended if the participant is very ill.
Trial Details
NCT Number NCT04419870
Lead Sponsor National Human Genome Research Institute (NHGRI)
Conditions Mitochondrial Disease
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov